Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Natasa Radojkovic Gligic

Natasa Radojkovic Gligic

University of Belgrade, Serbia

Title: Epileptic phenomena, differential diagnosis, delirium in case of an acute stroke patients that have been diagnosed with vascular dementia in the past

Biography

Biography: Natasa Radojkovic Gligic

Abstract

Patients who have psychiatric illness, dementia or brain tumors can go through real diagnostic procedures and therapy for a long time. non-convulsive epileptic seizures are often unrecognized as transient confusional conditions in younger patients, which require the introduction of electrocenography into the protocol in our patients. The main aim of this research is to monitor patients with dementia, with MMSE score from 16 to 22, when the patients’ age is between 68 and 75 years. All of the patients had vascular dementia earlier and were women. We conducted protocol diagnostics and gave psychiatric therapy that they otherwise received before arriving in our institution and consult. The protocol includes CT endocranium, Doppler, MKSC, and TCD. In general, patients have fallen into delirious conditions that had been more or less successfully treated with haloperidol, risperidone and benzodiazepines. This has been standard for years in the world, and we have included the mandatory EEG procedure for these patients. There were 25 patients who were monitored, and indicated a clear epileptic activity mainly of FT or TO regions. We started with a small dose of lamotrigine, and a gradual introduction of it. First of all, in the context of delirious conditions, these are visible hallucinations and lamentations, crying and sometimes fear. After the introduction of antiepileptic’s, such symptoms have disappeared, gradually, with patient dosing and neurophysiological monitoring.